Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker
Radiology · 2023
DOI: 10.1148/radiol.231661 ↗Kurz gefasst
Editorial in der Zeitschrift Radiology, 2023. Verfasst von Ramiro J Méndez und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Radiology Department, Hospital Clínico San Carlos, C/Profesor Martín Lagos s/n, 28040 Madrid, Spain (R.J.M.); and Radiology Department, Hosp…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Radiology Department, Hospital Clínico San Carlos, C/Profesor Martín Lagos s/n, 28040 Madrid, Spain (R.J.M.); and Radiology Department, Hospital Clinic of Barcelona, Barcelona, Spain (J.R.A.).
ORCID-Profile: Ramiro J Méndez, Juan R Ayuso
Zitieren
APA
Méndez, R. J., & Ayuso, J. R. (2023). Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker. Radiology. https://doi.org/10.1148/radiol.231661
Vancouver
Méndez RJ, Ayuso JR. Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker. Radiology. 2023. doi:10.1148/radiol.231661
BibTeX
@article{Mndez2023,
author = {Méndez, Ramiro J and Ayuso, Juan R},
title = {Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker},
journal = {Radiology},
year = {2023},
doi = {10.1148/radiol.231661}
}
EUVIMED